Development of Oral Natruiretic Peptides for Congestive Heart Failure [ 2011 - 2013 ]

Research Grant

Researchers: Prof Geoffrey Head (Principal investigator) ,  Dr Melissa Byrne ,  Prof David Kaye

Brief description Congestive heart failure is fatal disease and a major disease burden for the community affecting nearly half a million Australians. Current therapies are inadequate. We seek to develop a new peptide therapy based on snake venom version of the human B type natriuretic peptide which has to be given by injection. We will produce an orally active, stable and effective treatment using a program of discovery involving testing in animals and cells.

Funding Amount $AUD 511,037.36

Funding Scheme NHMRC Development Grants

Notes Development Grant